Biomolecular Recognition and Immobilization are fundamental processes in biotechnology and biochemistry that involve the specific binding and attachment of biomolecules to surfaces or other molecules. These processes play crucial roles in various applications, including biosensors, diagnostics, drug discovery, and biocatalysis. Biomolecular recognition refers to the selective interaction between biomolecules, such as proteins, nucleic acids, or carbohydrates, and their complementary binding partners, driven by specific molecular recognition events, such as hydrogen bonding, electrostatic interactions, or hydrophobic interactions. This recognition enables the precise and selective detection, capture, or manipulation of target biomolecules in complex biological samples. Immobilization involves the attachment or confinement of biomolecules to solid supports, matrices, or surfaces, thereby enhancing their stability, functionality, and accessibility for various applications. Immobilization strategies can range from physical adsorption or entrapment to covalent attachment or affinity-based methods, depending on the desired properties and applications of the immobilized biomolecules. Immobilization techniques not only facilitate the handling and manipulation of biomolecules but also enable the development of robust and reusable bio analytical platforms and bio catalytic systems.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy